Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Trichosanthes kirilowii extract helps wounds heal faster.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Tofacitinib might be used to treat hair loss.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Targeting PTEN can improve healing in venous leg ulcers.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

ZPK helps skin cells mature and may affect skin health.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

XEDAR triggers a specific signaling pathway in cells.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

TGF-β3 controls stem cell growth and development, varying by cell type and conditions.